Metraipolis › archive › dc_d232c0052525

Telitacicept as a novel B cell-targeted therapy in autoimmune encephalitis: a case report — Europe PMC PMID:41019070

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41019070
DOI: 10.3389/fimmu.2025.1640790
License (as archived): solo-consultazione
Archived: 2026-11-09T23:53:28.316Z
SHA-256 of the archived text: fb87111101f500e66ee9130681eb558ae6055c6535c9102e7680298161735637
Stable URL of this page: https://metraipolis.com/documento/dc_d232c0052525

How to cite

Telitacicept as a novel B cell-targeted therapy in autoimmune encephalitis: a case report — Europe PMC PMID:41019070 — Europe PMC (en), https://europepmc.org/article/MED/41019070 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d232c0052525 (Metraipolis archive dc_d232c0052525, sha256 fb87111101f500e66ee9130681eb558ae6055c6535c9102e7680298161735637)

BibTeX

@misc{dcd232c0052525,
  title = {Telitacicept as a novel B cell-targeted therapy in autoimmune encephalitis: a case report — Europe PMC PMID:41019070},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41019070},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d232c0052525; sha256 fb87111101f500e66ee9130681eb558ae6055c6535c9102e7680298161735637},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41019070. Agents can read the archived copy with the MCP tool read_document.